课题基金 / 基金详情

A model for Group C Medulloblastoma induced by deletion of RB1 and p53 tumor suppressors

A model for Group C Medulloblastoma induced by deletion of RB1 and p53 tumor suppressors
RB1和p53抑癌基因缺失诱导的C组髓母细胞瘤模型
批准号:
290822
负责人:
Zacksenhaus Eldad
金额:
$35.47万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-09-01 至 2017-09-01

项目摘要

项目成果

Zacksenhaus Eldad的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Medulloblastoma (MB) is a pediatric malignancy of the brain for which no good therapy is currently available. Patients are treated surgically, by radiation and by cytotoxic chemotherapy. Even when cure is achieved, the radiation treatment causes serious l
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prevention of metastatic triple negative breast cancer (TNBC) by targeting shared- and metastasis-enriched oncogenic pathways
  • 批准号:
    494896
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2023
  • 负责人:
    Zacksenhaus Eldad
  • 依托单位:
New mouse models and targeted therapies for aggressive forms of germline and sporadic pineoblastoma
  • 批准号:
    443784
  • 项目类别:
    Operating Grants
  • 资助金额:
    $69.66万
  • 财政年份:
    2021
  • 负责人:
    Zacksenhaus Eldad
  • 依托单位:
Mechanisms of diabetes and aging in constitutively active, phosphorylation-resistant pRb knockin mice
  • 批准号:
    450441
  • 项目类别:
    Operating Grants
  • 资助金额:
    $1.21万
  • 财政年份:
    2021
  • 负责人:
    Zacksenhaus Eldad
  • 依托单位:
Mechanisms of diabetes and aging in constitutively active, phosphorylation-resistant pRb knockin mice
  • 批准号:
    443790
  • 项目类别:
    Operating Grants
  • 资助金额:
    $58.24万
  • 财政年份:
    2021
  • 负责人:
    Zacksenhaus Eldad
  • 依托单位:
海外基金